[go: up one dir, main page]

PT768867E - Forma de dosagem para a administracao de droga em formulacao liquida - Google Patents

Forma de dosagem para a administracao de droga em formulacao liquida

Info

Publication number
PT768867E
PT768867E PT94920203T PT94920203T PT768867E PT 768867 E PT768867 E PT 768867E PT 94920203 T PT94920203 T PT 94920203T PT 94920203 T PT94920203 T PT 94920203T PT 768867 E PT768867 E PT 768867E
Authority
PT
Portugal
Prior art keywords
dosage form
drug
administration
liquid formulation
disclosed
Prior art date
Application number
PT94920203T
Other languages
English (en)
Inventor
George V Guittard
Wong S-L Patrick
Steven D Larsen
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PT768867E publication Critical patent/PT768867E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT94920203T 1994-06-13 1994-06-13 Forma de dosagem para a administracao de droga em formulacao liquida PT768867E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/006723 WO1995034285A1 (en) 1994-06-13 1994-06-13 Dosage form for administering drug in liquid formulation

Publications (1)

Publication Number Publication Date
PT768867E true PT768867E (pt) 2003-01-31

Family

ID=22242671

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94920203T PT768867E (pt) 1994-06-13 1994-06-13 Forma de dosagem para a administracao de droga em formulacao liquida

Country Status (11)

Country Link
EP (1) EP0768867B1 (pt)
JP (1) JP3901727B2 (pt)
KR (1) KR100360636B1 (pt)
AT (1) ATE225647T1 (pt)
AU (1) AU682703B2 (pt)
CA (1) CA2185119C (pt)
DE (1) DE69431533T2 (pt)
DK (1) DK0768867T3 (pt)
ES (1) ES2183841T3 (pt)
PT (1) PT768867E (pt)
WO (1) WO1995034285A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
CA2306448A1 (en) 1997-10-16 1999-04-22 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
HU226669B1 (en) * 1998-09-09 2009-06-29 Alza Corp Dosage form comprising liquid formulation
PT1140012E (pt) * 1998-12-17 2004-05-31 Alza Corp Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
UY28056A1 (es) * 2002-10-31 2003-12-31 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US8246986B2 (en) 2003-09-26 2012-08-21 Alza Corporation Drug coating providing high drug loading
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
EP2170283B1 (en) 2007-06-22 2019-01-09 Board of Regents, The University of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
US8779094B2 (en) 2008-11-16 2014-07-15 Board Of Regents, The University Of Texas System Low viscosity highly concentrated suspensions
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
EP3458084B1 (en) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
JP7195345B2 (ja) 2018-03-05 2022-12-23 アムニール コンプレックス プロダクツ リサーチ エルエルシー 薬物の時間放出のためのプログラム可能な医薬組成物
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
WO2020181127A1 (en) 2019-03-05 2020-09-10 Kashiv Biosciences, Llc Delayed release methylphenidate compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814180A (en) * 1984-03-21 1989-03-21 Alza Corporation Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug

Also Published As

Publication number Publication date
EP0768867A1 (en) 1997-04-23
JP3901727B2 (ja) 2007-04-04
EP0768867B1 (en) 2002-10-09
DK0768867T3 (da) 2002-10-28
WO1995034285A1 (en) 1995-12-21
DE69431533D1 (de) 2002-11-14
DE69431533T2 (de) 2003-10-02
CA2185119C (en) 2005-07-26
JPH10501261A (ja) 1998-02-03
KR970703752A (ko) 1997-08-09
AU682703B2 (en) 1997-10-16
ATE225647T1 (de) 2002-10-15
CA2185119A1 (en) 1995-12-21
KR100360636B1 (ko) 2002-12-18
AU7108094A (en) 1996-01-05
ES2183841T3 (es) 2003-04-01

Similar Documents

Publication Publication Date Title
PT768867E (pt) Forma de dosagem para a administracao de droga em formulacao liquida
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
IT1195823B (it) Dispositivo erogatore per la somministrazione di un agente benefico all ambiente d uso particolarmente per la somministrazione di un agente terapeutico ad un animale ruminante
DE3679908D1 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
IT1195820B (it) Dispositivo erogatore per la somministrazione di un agente benefico all ambiente d uso particolarmente per animali ruminanti
GEP20063773B (en) Steroid Sulphatase Inhibitors
AR240399A1 (es) Dispositivo suministrador para administrar una formulacion de agente beneficioso a un ambiente de uso.
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
HK1038508A1 (en) Dosage form comprising liquid formulation
DE60019334D1 (de) Antivirale arznei
GB9212450D0 (en) New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
NZ320237A (en) Stable pharmaceutical forms of administration containing parathormone
ITMI931326A1 (it) Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
MY108692A (en) Topical composition
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
HK1029277A1 (en) Pharmaceutical coating composition and method of use.
ZA957811B (en) The use of needle-free pressure-actuated injection devices for the administration of active substances to plants
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.
ZA944103B (en) Dosage form for administering drug in liquid formulation
TH19526A (th) วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน